Beacon Financial Group’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$285K Buy
4,129
+1,245
+43% +$85.9K 0.03% 291
2025
Q1
$200K Buy
2,884
+177
+7% +$12.3K 0.02% 330
2024
Q4
$233K Buy
2,707
+195
+8% +$16.8K 0.03% 310
2024
Q3
$299K Buy
2,512
+646
+35% +$76.9K 0.03% 283
2024
Q2
$266K Buy
1,866
+32
+2% +$4.57K 0.03% 284
2024
Q1
$235K Buy
+1,834
New +$235K 0.03% 298
2015
Q2
Sell
-29,168
Closed -$798K 175
2015
Q1
$798K Buy
29,168
+1,876
+7% +$51.3K 0.18% 81
2014
Q4
$582K Buy
27,292
+360
+1% +$7.68K 0.12% 108
2014
Q3
$651K Sell
26,932
-168
-0.6% -$4.06K 0.14% 102
2014
Q2
$622K Buy
27,100
+4,914
+22% +$113K 0.14% 100
2014
Q1
$501K Sell
22,186
-74
-0.3% -$1.67K 0.1% 119
2013
Q4
$411K Buy
22,260
+1,580
+8% +$29.2K 0.08% 141
2013
Q3
$351K Buy
+20,680
New +$351K 0.08% 140